Company:  ZIOPHARM ONCOLOGY INC (ZIOP)
Form Type:  8-K
Filing Date:  8/8/2019 
CIK:  0001107421 
Address:  ONE FIRST AVENUE
PARRIS BUILDING 34, NAVY YARD PLAZA
 
City, State, Zip:  BOSTON, Massachusetts 02129 
Telephone:  617-259-1970 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.73  
Change: 
0.00 (0.00%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$768.88M
Trade ZIOP now with

© 2019  
Description of Business
We are a biopharmaceutical company focused on discovering, acquiring, developing and commercializing next generation immunotherapy platforms that leverage cell- and gene-based therapies to treat patients with cancer. We are developing two immuno-oncology platform technologies that utilize the patient's immune system by employing novel, controlled gene expression and innovative cell engineering technologies to designed deliver safe, effective, and scalable cell- and viral-based therapies for the treatment of multiple cancer types. Our first platform is referred to as Sleeping Beauty and is based on the genetic engineering of immune cells using a non-viral transposon/transposase system to stably reprogram T cells outside of the body for subsequent infusion.
Register and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02 Results of Operations and Financial Condition
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits
    SIGNATURES
  EXHIBIT 99.1
    INCOME STATEMENT